6658 (6658) Fair Value & Analysis

Consumer Defensive · Market cap HK$13.8B

6 6658 6658 · HK

PriceHK$175.50

Fair ValueHK$43.44

Upside-75.2%

Quality58/100

Watch 6658 for free — get notified when fair value or trend changes. Watch for free

Evidence: Medium Range HK$30.41 – HK$56.48

Fair value as of: Jul 2, 2026

From 14 valuation models · updated today

Price vs Fair Value (1 month)

1‑month range HK$126.00 – HK$175.50 · fair‑value band HK$30.41 – HK$56.48 · the HK$175.50 price screens above the HK$43.44 fair value. As of Jul 2, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

6658 (6658) currently trades at HK$175.50, while our model-based Fair Value estimate is HK$43.44 — implying the stock looks roughly 75.2% overvalued today. We read business quality at 58/100 (solid quality), in the Consumer Defensive sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

Over the trailing twelve months, 6658 generated revenue of HK$1.7B at a net margin of 10.6%. It earns a return on equity of 24.3%. Net debt stands at HK$444M. The stock trades on a trailing P/E of 65.7. Fundamentals as of Jul 2, 2026

Key figures & financial health

Revenue (TTM) HK$1.7B

Net margin 10.6%

Return on equity 24.3%

Free cash flow −HK$94.2M FY2025

P/E ratio 65.7

Operating margin 13.4%

More key figures

Net debt HK$444M FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 2, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2023 – FY2025 · reported fiscal years

6658 reported revenue of HK$1.7B in FY2025 versus HK$1.3B in FY2023, a compound +13.8%/yr. Reported net income was HK$182M in FY2025, compounding +35.5%/yr from FY2023.

Revenue +13.8%/yr

FY23 HK$1.3B

FY24 HK$1.6B

FY25 HK$1.7B

Net income +35.5%/yr

FY23 HK$99.2M

FY24 HK$148M

FY25 HK$182M

Is 6658 fairly valued? → Check now

Similar stocks

6 more Packaged Foods stocks, each showing price versus our Fair Value estimate (as of Jul 2, 2026).

Stock	Price	Fair Value	vs Fair Value
Nestlé S.A NESN	CHF 79.73	CHF 55.79	-30%
Foshan Haitian Flavouring and Food Company 603288	¥35.10	¥25.34	-28%
Nestlé India Limited NESTLEIND	₹1,386	₹278.10	-80%
3288 3288	HK$30.26	HK$27.44	-9%
Grupo Bimbo, S.A. BIMBOA	57.10 MXN	72.19 MXN	+26%
Uni-President Enterprises Corp 1216	75.60 TWD	55.53 TWD	-27%

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks

Frequently asked questions

Is 6658 (6658) undervalued?

As of Jul 2, 2026, our model estimates a fair value of HK$43.44 versus a price of HK$175.50 — about −75% (overvalued). Model-based estimate, not financial advice.

What is the fair value of 6658?

Our model-based fair value for 6658 is HK$43.44 (as of Jul 2, 2026), built from audited fundamentals. The current price is HK$175.50.

What is the quality score of 6658?

6658 has a Quality Score of 58/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

What is the revenue of 6658 (6658)?

6658 reported trailing-twelve-month revenue of about HK$1.7B (latest available figure, as of Jul 2, 2026).

What is the net profit margin of 6658?

The net profit margin of 6658 is about 10.6%, meaning it keeps roughly 10.6% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.